Clinical Trials in Baise City, China
1 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Gastric CancerGastroesophageal-junction CancerHER2-positive Gastric Cancer+1 more
Shanghai Henlius Biotech550 enrolled208 locationsNCT06532006
Recruiting
Phase 2
Evaluating the Clinical Efficacy and Safety of Luspatercept Combined With Thalidomide in the Treatment of β-TDT Patients
Transfusion-dependent β-thalassemia Patients
Rongrong Liu78 enrolled8 locationsNCT07338344
Recruiting
Phase 4
ASPIrin in Reducing Events in Dialysis ( ASPIRED )
CKD (Chronic Kidney Disease) Stage 5D
Guangdong Provincial People's Hospital9,000 enrolled139 locationsNCT04381143
Recruiting
A Multi-center Study on Artificial Intelligence-Based Quantitative Evaluation of Echocardiography
Artificial Intelligence (AI)Cardiovascular Diseases (CVD)Echocardiography+1 more
First Hospital of China Medical University1,600 enrolled37 locationsNCT07133516
Recruiting
Not Applicable
Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma by AJCC V8 Stage
Fourth Affiliated Hospital of Guangxi Medical University288 enrolled9 locationsNCT05717790